- Home
- WEYS vs CATX Comparison
WEYS vs CATX Comparison
Compare WEYS & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEYS
- CATX
- Stock Information
- Founded
- WEYS 1906
- CATX 1983
- Country
- WEYS United States
- CATX United States
- Employees
- WEYS N/A
- CATX N/A
- Industry
- WEYS Apparel
- CATX Medical/Dental Instruments
- Sector
- WEYS Consumer Staples
- CATX Health Care
- Exchange
- WEYS Nasdaq
- CATX Nasdaq
- Market Cap
- WEYS 294.5M
- CATX 239.0M
- IPO Year
- WEYS N/A
- CATX N/A
- Fundamental
- Price
- WEYS $30.48
- CATX $3.28
- Analyst Decision
- WEYS
- CATX Strong Buy
- Analyst Count
- WEYS 0
- CATX 11
- Target Price
- WEYS N/A
- CATX $12.90
- AVG Volume (30 Days)
- WEYS 10.5K
- CATX 696.8K
- Earning Date
- WEYS 11-04-2025
- CATX 11-11-2025
- Dividend Yield
- WEYS 3.58%
- CATX N/A
- EPS Growth
- WEYS N/A
- CATX N/A
- EPS
- WEYS 2.69
- CATX N/A
- Revenue
- WEYS $281,051,000.00
- CATX $1,235,000.00
- Revenue This Year
- WEYS N/A
- CATX N/A
- Revenue Next Year
- WEYS N/A
- CATX N/A
- P/E Ratio
- WEYS $11.19
- CATX N/A
- Revenue Growth
- WEYS N/A
- CATX N/A
- 52 Week Low
- WEYS $25.51
- CATX $1.60
- 52 Week High
- WEYS $41.05
- CATX $14.19
- Technical
- Relative Strength Index (RSI)
- WEYS 51.56
- CATX 45.00
- Support Level
- WEYS $29.17
- CATX $3.02
- Resistance Level
- WEYS $30.76
- CATX $3.74
- Average True Range (ATR)
- WEYS 0.89
- CATX 0.25
- MACD
- WEYS 0.01
- CATX -0.01
- Stochastic Oscillator
- WEYS 56.22
- CATX 31.33
About WEYS Weyco Group Inc.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.